American Journal of Medical Case Reports
ISSN (Print): 2374-2151 ISSN (Online): 2374-216X Website: http://www.sciepub.com/journal/ajmcr Editor-in-chief: Samy, I. McFarlane
Open Access
Journal Browser
Go
American Journal of Medical Case Reports. 2021, 9(1), 22-23
DOI: 10.12691/ajmcr-9-1-7
Open AccessCase Report

Acute Subdural Hematoma with Negative Fibrin/Fibrinogen Degradation Product Findings

China Goto1, , Aito Watanabe2 and Youichi Yanagawa1

1Department of Acute Critical Care Medicine, Shizuoka hospital, Juntendo University, Shizuoka, Japan

2Neurosurgery, Shizuoka hospital, Juntendo University, Shizuoka, Japan

Pub. Date: October 26, 2020

Cite this paper:
China Goto, Aito Watanabe and Youichi Yanagawa. Acute Subdural Hematoma with Negative Fibrin/Fibrinogen Degradation Product Findings. American Journal of Medical Case Reports. 2021; 9(1):22-23. doi: 10.12691/ajmcr-9-1-7

Abstract

Traumatic acute subdural hematoma (ASDH) patients are generally positive for fibrin/fibrinogen degradation product (FDP) or d-dimer. We herein report a patient with negative FDP findings who had ASDH on computed tomography (CT). A 71-year-old woman was hit by a light truck while riding on a motorcycle. She suffered recent memory disturbance. The FDP level after arrival at the hospital was negative; however, she had right, thin ASDH on CT. The post-admission course was uneventful. The takeaway from the present case is that physicians cannot deny the possibility of ASDH even when the FDP level in the acute phase is within the normal limits.

Keywords:
acute subdural hematoma fibrin/fibrinogen degradation product computed tomography

Creative CommonsThis work is licensed under a Creative Commons Attribution 4.0 International License. To view a copy of this license, visit http://creativecommons.org/licenses/by/4.0/

References:

[1]  Sugimoto, K., Suehiro, E., Shinoyama, M., Sadahiro, H., Haji, K., Fujiyama, Y., Kawano, R., Nishioka, M. and Suzuki, M. “D-Dimer Elevation as a Blood Biomarker for Detection of Structural Disorder in Mild Traumatic Brain Injury” J Neurotrauma, 34(23). 3245-8. 2017.
 
[2]  Nakae, R., Takayama, Y., Kuwamoto, K., Naoe, Y., Sato, H. and Yokota, H. “Time Course of Coagulation and Fibrinolytic Parameters in Patients with Traumatic Brain Injury” J Neurotrauma. 33(7). 688-95. 2016 Apr.
 
[3]  Karri, J., Cardenas, J.C., Matijevic, N., Wang, Y.W., Choi, S., Zhu, L., Cotton, B.A., Kitagawa, R., Holcomb, J.B. and Wade, C.E. “Early Fibrinolysis Associated with Hemorrhagic Progression Following Traumatic Brain Injury” Shock. 48(6). 644-650. 2017 Dec.
 
[4]  Hagiwara, S., Oshima, K., Aoki, M., Murata, M., Ishihara, K., Kaneko, M., Furukawa, K., Nakamura, T, Ohyama, Y. and Tamura, J. “Usefulness of fibrin degradation products and d-dimer levels as biomarkers that reflect the severity of trauma” J Trauma Acute Care Surg. 74(5).1275-8. 2013 May.
 
[5]  Ishikawa, K, Omori, K., Jitsuiki, K, Ohsaka, H., Ito, H., Shimoyama, K., Fukunaga, T., Urabe, N., Kitamura, S. and Yanagawa, Y. “Clinical Significance of Fibrinogen Degradation Product Among Traumatized Patients” Air Med J. 36(2). 59-61. 2017 Mar-Apr.
 
[6]  Yanagawa, Y, Ishikawa, K., Jitsuiki, K., Yoshizawa, T., Oode, Y., Omori, K. and Ohsaka H. “Fibrinogen degradation product levels on arrival for trauma patients requiring a transfusion even without head injury” World J Emerg Med. 8(2).106-109. 2017.
 
[7]  Bayir, A., Kalkan, E., Koçak, S., Ak, A., Cander, B. and Bodur, S. “Fibrinolytic markers and neurologic outcome in traumatic brain injury” Neurol India. 54(4).363-5. 2006 Dec.
 
[8]  Nakae, R., Takayama, Y., Kuwamoto, K., Naoe, Y., Sato, H. and Yokota, H. “Time Course of Coagulation and Fibrinolytic Parameters in Patients with Traumatic Brain Injury” J Neurotrauma. 33(7). 688-95. 2016 Apr.